Ratings by Guggenheim (Yatin Suneja)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/10/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2026 | Climb Bio | CLYM | New Coverage | Buy (N/A) |
10.55 (12.66) |
20% | Details | |
| 6/1/2026 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2026 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2026 | Oculis Holding AG | OCS | New Coverage | Buy (N/A) |
27.96 (11.74) |
-58.01% | Details | |
| 5/15/2026 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 5/15/2026 | Alumis Inc | ALMS | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2026 | Sionna Therapeutics | SION | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2026 | EyePoint Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2026 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2026 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | Inflarx NV | IFRX | Maintain | Buy (Buy) |
|
Details | ||
| 4/13/2026 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2026 | Oruka Therapeutics | ORKA | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2026 | Forte Biosciences Inc. | FBRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 3/30/2026 | Neumora Therapeutics | NMRA | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Alumis Inc | ALMS | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Surrozen Inc. | SRZN | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
1.10 (15.07) |
1270% | Details | |
| 3/23/2026 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | Avalo Therapeutics Inc. | AVTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2026 | Inflarx NV | IFRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2026 | Larimar Therapeutics | LRMR | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Zenas Biopharma | ZBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | EyePoint Inc. | EYPT | Maintain | Buy (Buy) |
|
Details | ||
| 3/13/2026 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2026 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Sionna Therapeutics | SION | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2026 | EyePoint Inc. | EYPT | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2026 | Stoke Therapeutics | STOK | New Coverage | Buy (N/A) |
33.79 (30.40) |
-10.03% | Details | |
| 2/2/2026 | DBV Technologies S.A | DBVT | Maintain | Buy (Buy) |
|
Details | ||
| 2/2/2026 | Avalo Therapeutics Inc. | AVTX | New Coverage | Buy (N/A) |
15.11 (18.00) |
19.13% | Details | |
| 1/27/2026 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 1/20/2026 | Rapt Therapeutics | RAPT | Downgrade | Neutral (Buy) |
35.10 (58.02) |
65.3% | Details | |
| 1/13/2026 | Abivax | ABVX | Maintain | Buy (Buy) |
|
Details | ||
| 1/7/2026 | Alumis Inc | ALMS | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (Buy) |
|
Details | ||
| 12/19/2025 | SAB Biotherapeutics | SABS | New Coverage | Buy (N/A) |
3.95 (3.87) |
-2.03% | Details | |
| 12/18/2025 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2025 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | DBV Technologies S.A | DBVT | New Coverage | Buy (N/A) |
12.90 (16.02) |
24.19% | Details | |
| 11/11/2025 | Inflarx NV | IFRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2025 | Neumora Therapeutics | NMRA | Upgrade | Buy (Neutral) |
2.63 (1.51) |
-42.59% | Details | |
| 10/27/2025 | Oruka Therapeutics | ORKA | New Coverage | Buy (N/A) |
27.25 (86.63) |
217.91% | Details | |
| 10/27/2025 | Rapt Therapeutics | RAPT | New Coverage | Buy (N/A) |
29.53 (35.10) |
18.86% | Details | |
| 10/16/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2025 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2025 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2025 | Spyre | SYRE | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2025 | AnaptysBio | ANAB | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2025 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2025 | Larimar Therapeutics | LRMR | Maintain | Buy (Buy) |
|
Details | ||
| 9/15/2025 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2025 | Tourmaline Bio | TRML | Downgrade | Neutral (Buy) |
30.18 (47.98) |
58.98% | Details | |
| 9/8/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2025 | Spyre | SYRE | Maintain | Buy (Buy) |
|
Details | ||
| 8/18/2025 | Forte Biosciences Inc. | FBRX | New Coverage | Buy (N/A) |
11.57 (18.71) |
61.71% | Details | |
| 8/14/2025 | Larimar Therapeutics | LRMR | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | Sionna Therapeutics | SION | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2025 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2025 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2025 | Larimar Therapeutics | LRMR | Maintain | Buy (Buy) |
|
Details | ||
| 6/10/2025 | Alumis Inc | ALMS | New Coverage | Buy (N/A) |
3.43 (25.03) |
629.74% | Details | |
| 6/6/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 6/3/2025 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Spyre | SYRE | Maintain | Buy (Buy) |
|
Details | ||
| 5/30/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | Inflarx NV | IFRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2025 | Vigil Neuroscience Inc | VIGL | Downgrade | Neutral (Buy) |
2.31 (8.05) |
248.48% | Details | |
| 5/15/2025 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2025 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 4/10/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2025 | Inflarx NV | IFRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Zura Bio Ltd. | ZURA | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2025 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2025 | Neumora Therapeutics | NMRA | Downgrade | Neutral (Buy) |
1.52 (2.63) |
73.03% | Details | |
| 3/4/2025 | Sionna Therapeutics | SION | New Coverage | Buy (N/A) |
13.77 (42.77) |
210.6% | Details | |
| 3/3/2025 | Neumora Therapeutics | NMRA | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2025 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2025 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2025 | Surrozen Inc. | SRZN | Upgrade | Buy (Neutral) |
14.25 (24.52) |
72.07% | Details | |
| 1/3/2025 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
18.66 (23.72) |
27.12% | Details | |
| 12/30/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 12/16/2024 | Larimar Therapeutics | LRMR | Maintain | Buy (Buy) |
|
Details | ||
| 12/12/2024 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2024 | Zenas Biopharma | ZBIO | Maintain | Buy (Buy) |
|
Details | ||
| 12/11/2024 | Q32 Bio Inc. | QTTB | Downgrade | Neutral (Buy) |
24.41 (11.95) |
-51.04% | Details | |
| 11/26/2024 | Vigil Neuroscience Inc | VIGL | Maintain | Buy (Buy) |
|
Details | ||
| 11/14/2024 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 11/12/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Zura Bio Ltd. | ZURA | Maintain | Buy (Buy) |
|
Details | ||
| 11/7/2024 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (Buy) |
|
Details | ||
| 11/7/2024 | Adicet Bio Inc. | ACET | Maintain | Buy (Buy) |
|
Details | ||
| 11/7/2024 | AnaptysBio | ANAB | Maintain | Buy (Buy) |
|
Details | ||
| 11/6/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (Buy) |
|
Details | ||
| 11/4/2024 | Tourmaline Bio | TRML | Maintain | Buy (Buy) |
|
Details | ||
| 10/28/2024 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (Buy) |
|
Details | ||
| 10/25/2024 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2024 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (Buy) |
|
Details | ||
| 10/11/2024 | Tourmaline Bio | TRML | Maintain | Buy (Buy) |
|
Details | ||
| 10/8/2024 | Zenas Biopharma | ZBIO | New Coverage | Buy (N/A) |
18.81 (24.67) |
31.15% | Details | |
| 10/4/2024 | Dianthus Therapeutics | DNTH | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2024 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
1.43 (7.90) |
452.45% | Details | |
| 9/30/2024 | Abivax | ABVX | Maintain | Buy (Buy) |
|
Details | ||
| 9/25/2024 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2024 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2024 | Alumis Inc | ALMS | New Coverage | Buy (N/A) |
13.00 (3.43) |
-73.62% | Details | |
| 6/18/2024 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
36.55 (327.86) |
797.02% | Details | |
| 6/17/2024 | Q32 Bio Inc. | QTTB | New Coverage | Buy (N/A) |
18.61 (11.95) |
-35.79% | Details | |
| 6/11/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 5/30/2024 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | Rapt Therapeutics | RAPT | Downgrade | Neutral (Buy) |
7.98 (29.53) |
270.05% | Details | |
| 4/29/2024 | Abivax | ABVX | New Coverage | Buy (N/A) |
15.78 (92.37) |
485.36% | Details | |
| 3/27/2024 | Vigil Neuroscience Inc | VIGL | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2024 | Tourmaline Bio | TRML | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | Larimar Therapeutics | LRMR | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2023 | Karuna Therapeutics Inc. | KRTX | Downgrade | Neutral (Buy) |
215.19 (329.83) |
53.27% | Details | |
| 12/21/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2023 | Tourmaline Bio | TRML | New Coverage | Buy (N/A) |
14.85 (30.18) |
103.23% | Details | |
| 10/30/2023 | Dianthus Therapeutics | DNTH | New Coverage | Buy (N/A) |
11.90 (91.57) |
669.5% | Details | |
| 10/30/2023 | Dianthus Therapeutics | DNTH | New Coverage | Buy (N/A) |
11.90 (91.57) |
669.5% | Details | |
| 10/10/2023 | Neumora Therapeutics | NMRA | New Coverage | Buy (N/A) |
12.14 (1.52) |
-87.48% | Details | |
| 9/21/2023 | Seelos Therapeutics | SEEL | Downgrade | Neutral (Buy) |
0.31 (1.28) |
312.9% | Details | |
| 7/18/2023 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
12.49 (2.92) |
-76.62% | Details | |
| 7/17/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2023 | BioXcel Therapeutics | BTAI | Downgrade | Neutral (Buy) |
10.30 (1.25) |
-87.86% | Details | |
| 6/26/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2023 | Zura Bio Ltd. | ZURA | New Coverage | Buy (N/A) |
11.62 (4.54) |
-60.93% | Details | |
| 5/4/2023 | Neurocrine Bio. | NBIX | Upgrade | Buy (Neutral) |
98.62 (164.18) |
66.48% | Details | |
| 5/1/2023 | Moonlake Immunotherapeutics | MLTX | New Coverage | Buy (N/A) |
21.30 (19.99) |
-6.15% | Details | |
| 5/1/2023 | Biogen | BIIB | Upgrade | Buy (Neutral) |
304.23 (201.96) |
-33.62% | Details | |
| 4/17/2023 | Prometheus Biosciences Inc | RXDX | Downgrade | Neutral (Buy) |
114.01 (199.92) |
75.35% | Details | |
| 4/5/2023 | Inflarx NV | IFRX | Upgrade | Buy (Neutral) |
3.77 (1.86) |
-50.66% | Details | |
| 3/15/2023 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2023 | Immunovant | IMVT | Upgrade | Buy (Neutral) |
18.43 (38.24) |
107.49% | Details | |
| 1/4/2023 | Rapt Therapeutics | RAPT | New Coverage | Buy (N/A) |
18.61 (7.98) |
-57.12% | Details | |
| 1/3/2023 | Sage Therapeutics | SAGE | Downgrade | Neutral (Buy) |
38.67 (8.68) |
-77.55% | Details | |
| 1/3/2023 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Neutral) |
15.95 (23.72) |
48.71% | Details | |
| 1/3/2023 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2022 | Horizon Therapeutics | HZNP | Downgrade | Neutral (Buy) |
112.36 (116.30) |
3.51% | Details | |
| 12/7/2022 | Prometheus Biosciences Inc | RXDX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/18/2022 | Surrozen Inc. | SRZN | Downgrade | Neutral (Buy) |
1.11 (24.52) |
2109.01% | Details | |
| 11/11/2022 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Vigil Neuroscience Inc | VIGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Bausch & Lomb Corp. | BLCO | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | AnaptysBio | ANAB | Upgrade | Buy (Neutral) |
28.85 (59.68) |
106.86% | Details | |
| 10/19/2022 | Reata Pharmaceuticals | RETA | New Coverage | Buy (N/A) |
36.50 (172.36) |
372.22% | Details | |
| 10/19/2022 | Larimar Therapeutics | LRMR | New Coverage | Buy (N/A) |
3.45 (3.50) |
1.45% | Details | |
| 10/14/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 10/14/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Relmada Therapeutics Inc | RLMD | Downgrade | Neutral (Buy) |
6.47 (6.45) |
-0.31% | Details | |
| 9/6/2022 | Relmada Therapeutics Inc | RLMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Global Blood Therapeutics | GBT | Downgrade | Neutral (Buy) |
63.84 (68.49) |
7.28% | Details | |
| 7/29/2022 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2022 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 5/31/2022 | Bausch & Lomb Corp. | BLCO | New Coverage | Buy (N/A) |
17.69 (15.91) |
-10.06% | Details | |
| 5/9/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2022 | Eliem Therapeutics Inc. | ELYM | Downgrade | Neutral (Buy) |
6.51 (5.11) |
-21.51% | Details | |
| 4/7/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2022 | AnaptysBio | ANAB | Downgrade | Neutral (Buy) |
26.50 (59.68) |
125.21% | Details | |
| 3/2/2022 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2022 | Inflarx NV | IFRX | Downgrade | Neutral (Buy) |
3.01 (3.77) |
25.25% | Details | |
| 2/22/2022 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 2/1/2022 | Vigil Neuroscience Inc | VIGL | New Coverage | Buy (N/A) |
12.90 (8.05) |
-37.6% | Details | |
| 1/19/2022 | Zogenix, Inc. | ZGNX | Downgrade | Neutral (Buy) |
15.64 (26.68) |
70.59% | Details | |
| 1/13/2022 | Biogen | BIIB | Downgrade | Neutral (Buy) |
225.34 (201.96) |
-10.38% | Details | |
| 12/21/2021 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
27.09 (23.72) |
-12.44% | Details | |
| 11/2/2021 | Sage Therapeutics | SAGE | Upgrade | Buy (Neutral) |
42.37 (8.68) |
-79.51% | Details | |
| 11/1/2021 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Neutral) |
17.95 (23.72) |
32.14% | Details | |
| 10/29/2021 | argenx SE | ARGX | Upgrade | Buy (Neutral) |
279.58 (888.65) |
217.85% | Details | |
| 10/25/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2021 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2021 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2021 | Surrozen Inc. | SRZN | New Coverage | Buy (N/A) |
10.13 (24.52) |
142.05% | Details | |
| 9/7/2021 | Eliem Therapeutics Inc. | ELYM | New Coverage | Buy (N/A) |
27.56 (5.11) |
-81.46% | Details | |
| 8/10/2021 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2021 | Celldex Therapeutics | CLDX | New Coverage | Buy (N/A) |
43.30 (34.09) |
-21.27% | Details | |
| 7/1/2021 | Seelos Therapeutics | SEEL | New Coverage | Buy (N/A) |
2.64 (1.28) |
-51.52% | Details | |
| 6/21/2021 | Orphazyme | ORPH | Downgrade | Buy (Sell) |
7.33 (0.87) |
-88.13% | Details | |
| 6/15/2021 | Sage Therapeutics | SAGE | Downgrade | Neutral (Buy) |
72.86 (42.37) |
-41.85% | Details | |
| 6/9/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2021 | Immunovant | IMVT | Downgrade | Neutral (Buy) |
15.16 (38.24) |
152.24% | Details | |
| 4/23/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2021 | Phathom Pharmaceuticals | PHAT | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2021 | Inflarx NV | IFRX | Upgrade | Buy (N/A) |
4.30 (1.86) |
-56.74% | Details | |
| 3/9/2021 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
45.78 (23.72) |
-48.19% | Details | |
| 2/2/2021 | Phathom Pharmaceuticals | PHAT | New Coverage | Buy (N/A) |
38.50 (10.34) |
-73.14% | Details | |
| 1/4/2021 | Sage Therapeutics | SAGE | Upgrade | Buy (Neutral) |
86.51 (72.86) |
-15.78% | Details | |
| 11/4/2020 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2020 | Orphazyme | ORPH | New Coverage | Buy (N/A) |
10.07 (0.87) |
-91.36% | Details | |
| 10/14/2020 | AnaptysBio | ANAB | Upgrade | Buy (Neutral) |
17.76 (59.68) |
236.04% | Details | |
| 8/18/2020 | Principia Biopharma | PRNB | Downgrade | Neutral (Buy) |
99.25 (100.05) |
0.81% | Details | |
| 8/17/2020 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2020 | Arena Pharma | ARNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2020 | Principia Biopharma | PRNB | New Coverage | Buy (N/A) |
56.00 (99.25) |
77.23% | Details | |
| 6/4/2020 | BioXcel Therapeutics | BTAI | New Coverage | Buy (N/A) |
45.14 (1.25) |
-97.23% | Details | |
| 5/26/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2020 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2020 | Sage Therapeutics | SAGE | Downgrade | Neutral (Buy) |
29.03 (8.68) |
-70.1% | Details | |
| 3/19/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2020 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2020 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2020 | Zogenix, Inc. | ZGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/27/2020 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2019 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2019 | Acadia Pharmaceuticals | ACAD | New Coverage | Buy (N/A) |
44.34 (23.72) |
-46.5% | Details | |
| 12/16/2019 | Relmada Therapeutics Inc | RLMD | New Coverage | Buy (N/A) |
34.14 (6.47) |
-81.05% | Details | |
| 12/5/2019 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2019 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2019 | Exicure | XCUR | New Coverage | Buy (N/A) |
2.60 (2.52) |
-3.08% | Details | |
| 11/15/2019 | resTORbio Inc. | TORC | Downgrade | Neutral (Buy) |
7.95 (2.28) |
-71.32% | Details | |
| 11/13/2019 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2019 | AnaptysBio | ANAB | Downgrade | Neutral (Buy) |
36.16 (59.68) |
65.04% | Details | |
| 11/8/2019 | Ra Pharma | RARX | Downgrade | Neutral (Buy) |
46.90 (48.00) |
2.35% | Details | |
| 11/7/2019 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2019 | Biogen | BIIB | Upgrade | Buy (Neutral) |
281.87 (201.96) |
-28.35% | Details | |
| 10/16/2019 | Axsome Therapeutics | AXSM | New Coverage | Buy (N/A) |
20.63 (237.33) |
1050.41% | Details | |
| 9/23/2019 | Regeneron Pharma | REGn | Upgrade | Buy (Neutral) |
295.87 (620.14) |
109.6% | Details | |
| 9/20/2019 | Xenon Pharmaceuticals | XENE | New Coverage | Buy (N/A) |
9.23 (56.78) |
515.17% | Details | |
| 8/8/2019 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2019 | Neurocrine Bio. | NBIX | Maintain | Neutral (N/A) |
|
Details | ||
| 6/27/2019 | Zogenix, Inc. | ZGNX | Upgrade | Buy (Neutral) |
39.41 (15.64) |
-60.31% | Details | |
| 6/5/2019 | Inflarx NV | IFRX | Downgrade | Neutral (Buy) |
37.29 (1.86) |
-95.01% | Details | |
| 6/5/2019 | Neurocrine Bio. | NBIX | New Coverage | Neutral (N/A) |
82.16 (164.18) |
99.83% | Details | |
| 6/5/2019 | resTORbio Inc. | TORC | New Coverage | Buy (N/A) |
6.97 (7.95) |
14.06% | Details | |
| 5/7/2019 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2019 | Zogenix, Inc. | ZGNX | Downgrade | Neutral (Buy) |
51.85 (26.68) |
-48.54% | Details | |
| 4/9/2019 | Zogenix, Inc. | ZGNX | Downgrade | Neutral (Buy) |
52.00 (39.41) |
-24.21% | Details | |
| 3/22/2019 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 3/21/2019 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 3/20/2019 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2019 | Inflarx NV | IFRX | New Coverage | Buy (N/A) |
32.78 (37.29) |
13.76% | Details | |
| 2/22/2019 | GW Pharma | GWPH | New Coverage | Buy (N/A) |
145.88 (218.96) |
50.1% | Details | |
| 2/22/2019 | Global Blood Therapeutics | GBT | New Coverage | Buy (N/A) |
50.55 (68.49) |
35.49% | Details | |
| 2/22/2019 | Agile Therapeutics | AGRX | New Coverage | Buy (N/A) |
0.96 (1.51) |
57.29% | Details | |
| 2/22/2019 | AnaptysBio | ANAB | New Coverage | Buy (N/A) |
65.03 (36.16) |
-44.39% | Details | |
| 2/22/2019 | Sage Therapeutics | SAGE | New Coverage | Buy (N/A) |
147.66 (8.68) |
-94.12% | Details | |
| 2/22/2019 | Zogenix, Inc. | ZGNX | New Coverage | Buy (N/A) |
47.57 (52.00) |
9.31% | Details | |
| 2/22/2019 | Alexion Pharmaceuticals | ALXN | New Coverage | Neutral (N/A) |
129.84 (182.01) |
40.18% | Details | |
| 2/22/2019 | Biogen | BIIB | Downgrade | Neutral (Buy) |
335.16 (201.96) |
-39.74% | Details | |
| 2/22/2019 | Ra Pharma | RARX | New Coverage | Buy (N/A) |
18.54 (46.90) |
152.97% | Details | |
| 2/21/2019 | Regeneron Pharma | REGN | Downgrade | Neutral (Buy) |
422.51 (295.87) |
-29.97% | Details |
